loader
Please Wait
Applying Filters...
pipeline-prospector-insert-v1
X

List of DSSTox_CID_3370 Active Pharmaceutical Ingredient (API) suppliers/manufacturers & exporters

Client Email Product
Left Arrow
Right Arrow
Filters Filter
×
FILTER DATA :

filter

Nimodipine

filter

CHINA

INDIA

ITALY

SPAIN

Virtual BoothResearch-driven Global Pharmaceutical Company, focused on niche API for the Generic Industry.

Biophore is a research driven global pharmaceutical company focused on development, manufacturing and marketing of Active Pharmaceutical Ingredients (APIs) having its operations based in Hyderabad, India and also has a registered office in New Jersey, USA. Biophore has two dedicated R&D facilities in Hyderabad and Vishakapatnam. The research facili...
Biophore is a research driven global pharmaceutical company focused on development, manufacturing and marketing of Active Pharmaceutical Ingredients (APIs) having its operations based in Hyderabad, India and also has a registered office in New Jersey, USA. Biophore has two dedicated R&D facilities in Hyderabad and Vishakapatnam. The research facilities are fully equipped with wide range of R&D and process equipment from USA with reaction capabilities from milligram to kilogram.

Virtual BoothChemistry for a better life

With 80 years of experience, UQUIFA’S business model is based on a combination of a quality manufacturing platform and track record of service and reliability. UQUIFA is a manufacturer of Active Pharmaceutical Ingredients (APIs) and intermediates for the pharmaceutical and animal health industries globally. The Company has 3 manufacturing sites (...
With 80 years of experience, UQUIFA’S business model is based on a combination of a quality manufacturing platform and track record of service and reliability. UQUIFA is a manufacturer of Active Pharmaceutical Ingredients (APIs) and intermediates for the pharmaceutical and animal health industries globally. The Company has 3 manufacturing sites (2 in Spain and 1 in Mexico) with strict adherence to all regulatory norms. These sites operate under cGMP conditions and have been inspected and approved by leading global pharmaceutical companies and regulatory authorities, including the US FDA.

Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

In the dinamic pharmaceutical field, DEAFARMA is the reference point for primaries Pharmaceutical Laboratories for over twenty years, even in the national and international territory. DEAFARMA works with success in the pharmaceutical raw materials field through Agencies and professional relations with the most important European and Asiatic factori...
In the dinamic pharmaceutical field, DEAFARMA is the reference point for primaries Pharmaceutical Laboratories for over twenty years, even in the national and international territory. DEAFARMA works with success in the pharmaceutical raw materials field through Agencies and professional relations with the most important European and Asiatic factories. Our partners are well known, reliable producers and all of them are operating in accordance with the latest GMP Rules. The APIs mentioned in the DEAFARMA catalogue are always supported by DMF and/or CEP.

Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

Lusochimica S.p.A. is an Italian manufacturer of bulk active ingredients for pharmaceuticals (API), having sales offices in Milan and two production plants in Lomagna and Pisa, whose production processes strictly comply with international cGMP standards. Founded in 1964 and belonging to Menarini Group since 1984, Lusochimica S.p.A. incorporated f...
Lusochimica S.p.A. is an Italian manufacturer of bulk active ingredients for pharmaceuticals (API), having sales offices in Milan and two production plants in Lomagna and Pisa, whose production processes strictly comply with international cGMP standards. Founded in 1964 and belonging to Menarini Group since 1984, Lusochimica S.p.A. incorporated former Laboratori Guidotti Fine Chemicals division starting January 2009, as a result of restructuring of Fine Chemicals operations within Menarini Group. Lusochimica’s mission is to dedicate our cutting edge manufacturing technology to ensure supplying high quality active ingredients to our clients because, according to our vision, safety of human drugs must be the driving force of our daily actions.

Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

Established in 1943 as one of the national largest manufacturing and exporting bases in the chemical synthetic pharmaceuticals field, Shandong Xinhua Pharmaceutical Company Limited ("Shandong Xinhua") is in an leading position in the manufacturing technology and capacity for antipyretics and analgesics in China and is an important manufacturer in C...
Established in 1943 as one of the national largest manufacturing and exporting bases in the chemical synthetic pharmaceuticals field, Shandong Xinhua Pharmaceutical Company Limited ("Shandong Xinhua") is in an leading position in the manufacturing technology and capacity for antipyretics and analgesics in China and is an important manufacturer in China for the drugs for central nervous system, steroids, cardio cerebrovascular system as well as finished dosage forms and pharmaceutical intermediates. With implementing the global market development strategy and adopting the international advanced standards in quality management, Shandong Xinhua has been granted the certifications of GMP, ISO9001, ISO14001, ISO 10012, and ISO22000. The main products of Shandong Xinhua have been granted the COS Certificate from EDQM and passed the site inspection from USA FDA. By taking the advantages of its solid scientific research strength, well-established quality system, high market reputation as well as being a listing company of H shares and A shares with sound capital structure and product portfolio. "XINHUA" brand was honored with the title of "Chinese Famous Brand" in China. With the high commitment to the product quality and development of the international markets, the Company has established the strategic partnership with dozens of MNCs, the products of the Company has been distributed to more than 60 countries and regions.

PharmaCompass >>

First
Previous
Next
Last